R.J. Arceci

1.6k total citations · 1 hit paper
24 papers, 1.3k citations indexed

About

R.J. Arceci is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, R.J. Arceci has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Immunology. Recurrent topics in R.J. Arceci's work include Drug Transport and Resistance Mechanisms (6 papers), T-cell and Retrovirus Studies (4 papers) and Chronic Lymphocytic Leukemia Research (2 papers). R.J. Arceci is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), T-cell and Retrovirus Studies (4 papers) and Chronic Lymphocytic Leukemia Research (2 papers). R.J. Arceci collaborates with scholars based in United States, Hungary and Belgium. R.J. Arceci's co-authors include Stuart H. Orkin, David B. Wilson, Kimberly A. Stieglitz, Barbara E. Bierer, S J Burakoff, Kyri Dunussi‐Joannopoulos, Peter Nickerson, Strom Tb, HJ Weinstein and CM Niemeyer and has published in prestigious journals such as Blood, Molecular and Cellular Biology and Calcified Tissue International.

In The Last Decade

R.J. Arceci

24 papers receiving 1.3k citations

Hit Papers

Mouse GATA-4: a retinoic ... 1993 2026 2004 2015 1993 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart.
    1993 614 citations R.J. Arceci, Stuart H. Orkin et al. Molecular and Cellular Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.J. Arceci United States 10 848 458 217 188 149 24 1.3k
Laith Dabbagh Canada 15 549 0.6× 546 1.2× 60 0.3× 212 1.1× 111 0.7× 23 1.3k
A. A. Sandberg United States 18 471 0.6× 337 0.7× 240 1.1× 125 0.7× 86 0.6× 26 1.3k
Renee M. McGovern United States 22 693 0.8× 534 1.2× 129 0.6× 111 0.6× 140 0.9× 50 1.5k
J. Whang‐Peng United States 22 1.1k 1.3× 867 1.9× 375 1.7× 170 0.9× 103 0.7× 46 2.2k
Anne Talvensaari‐Mattila Finland 20 474 0.6× 615 1.3× 109 0.5× 121 0.6× 74 0.5× 60 1.4k
Jørgen K. Larsen Denmark 20 430 0.5× 290 0.6× 105 0.5× 284 1.5× 90 0.6× 57 1.2k
Kumiko Goi Japan 21 665 0.8× 356 0.8× 92 0.4× 191 1.0× 50 0.3× 78 1.2k
Alessandra Insinga Italy 12 1.1k 1.3× 371 0.8× 98 0.5× 141 0.8× 85 0.6× 12 1.5k
Tatyana A. Holzmayer United States 7 595 0.7× 609 1.3× 69 0.3× 62 0.3× 174 1.2× 10 1.0k
Nadine Pavloff United States 10 592 0.7× 452 1.0× 100 0.5× 143 0.8× 46 0.3× 17 1.6k

Countries citing papers authored by R.J. Arceci

Since Specialization
Citations

This map shows the geographic impact of R.J. Arceci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.J. Arceci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.J. Arceci more than expected).

Fields of papers citing papers by R.J. Arceci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.J. Arceci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.J. Arceci. The network helps show where R.J. Arceci may publish in the future.

Co-authorship network of co-authors of R.J. Arceci

This figure shows the co-authorship network connecting the top 25 collaborators of R.J. Arceci. A scholar is included among the top collaborators of R.J. Arceci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.J. Arceci. R.J. Arceci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Arceci, R.J.. (2011). Autoimmune Lymphoproliferative Syndrome Like Disease With Somatic KRAS Mutation. Yearbook of Oncology. 2011. 163–163. 2 indexed citations
3.
Arceci, R.J.. (2011). Prognostic Importance of Histone Methyltransferase MLL5 Expression in Acute Myeloid Leukemia. Yearbook of Oncology. 2011. 139–140. 3 indexed citations
4.
Arceci, R.J.. (2011). Nuclear ErbB2 Enhances Translation and Cell Growth by Activating Transcription of Ribosomal RNA Genes. Yearbook of Oncology. 2011. 206–207. 5 indexed citations
5.
Arceci, R.J.. (2006). Identification of OTX2 as a Medulloblastoma Oncogene Whose Product Can Be Targeted by All-Trans Retinoic Acid. Yearbook of Oncology. 2006. 341–342. 7 indexed citations
6.
7.
Goda, Katalin, László Bene, Margit Balázs, et al.. (2000). Conformational heterogeneity of P-glycoprotein.. PubMed. 24(5). 415–21. 4 indexed citations
8.
Dunussi‐Joannopoulos, Kyri, HJ Weinstein, Peter Nickerson, et al.. (1996). Irradiated B7-1 transduced primary acute myelogenous leukemia (AML) cells can be used as therapeutic vaccines in murine AML. Blood. 87(7). 2938–2946. 85 indexed citations
9.
Mangham, D. C., Setsuro Komiya, Roxanne Gendron, et al.. (1996). P-Glycoprotein Is Expressed in the Mineralizing Regions of the Skeleton. Calcified Tissue International. 58(3). 186–191. 3 indexed citations
10.
O’Connor, Rosemary, Cheng‐Che Liu, Yali Liu, et al.. (1995). Anti-B4-blocked ricin synergizes with doxorubicin and etoposide on multidrug-resistant and drug-sensitive tumors. Blood. 86(11). 4286–4294. 34 indexed citations
11.
Ritke, M K, Jack C. Yalowich, Marilyn L. Slovak, et al.. (1994). P-glycoprotein mediates profound resistance to bisantrene.. PubMed. 6(7). 291–301. 25 indexed citations
12.
Arceci, R.J., et al.. (1993). Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart.. Molecular and Cellular Biology. 13(4). 2235–2246. 614 indexed citations breakdown →
13.
Arceci, R.J.. (1993). Clinical significance of P-glycoprotein in multidrug resistance malignancies [editorial] [see comments]. Blood. 81(9). 2215–2222. 202 indexed citations
14.
Arceci, R.J., Kimberly A. Stieglitz, & Barbara E. Bierer. (1992). Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotype. Blood. 80(6). 1528–1536. 111 indexed citations
15.
Arceci, R.J., et al.. (1992). Role and Expression of Colony Stimulating Factor-1 and Steel Factor Receptors and their Ligands during Pregnancy in the Mouse. Reproduction Fertility and Development. 4(6). 619–632. 9 indexed citations
16.
Arceci, R.J., Kimberly A. Stieglitz, & Barbara E. Bierer. (1992). Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotype. Blood. 80(6). 1528–1536. 3 indexed citations
17.
18.
19.
Antin, JH, et al.. (1986). HTLV-III infection after bone marrow transplantation. Blood. 67(1). 160–163. 4 indexed citations
20.
Antin, JH, et al.. (1986). HTLV-III infection after bone marrow transplantation. Blood. 67(1). 160–163. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laith Dabbagh Breakdown of academic impact, for papers by A. A. Sandberg Breakdown of academic impact, for papers by Renee M. McGovern Breakdown of academic impact, for papers by J. Whang‐Peng Breakdown of academic impact, for papers by Anne Talvensaari‐Mattila Breakdown of academic impact, for papers by Jørgen K. Larsen Breakdown of academic impact, for papers by Kumiko Goi Breakdown of academic impact, for papers by Alessandra Insinga Breakdown of academic impact, for papers by Tatyana A. Holzmayer Breakdown of academic impact, for papers by Nadine Pavloff
Rankless by CCL
2026